Cardiovascular disease (CVD) remains a predominant global cause of mortality, with left ventricular hypertrophy (LVH) representing a significant risk factor for life-threatening cardiovascular incidents. Our study aimed to assess the impact of an ethanolic extract of Psidium guajava leaves (PGLE) on adrenaline-induced LVH in rats by evaluating lipid metabolism, cardiac biomarkers, and oxidative stress indicators. Swiss Albino rats were subjected to intraperitoneal injections of adrenaline (100 µL) over 14 days to induce LVH. PGLE was administered via oral gavage at three graded dose levels (100, 200, and 300 mg/kg body weight) for four weeks. The parameters measured included total cholesterol, triglycerides, low-density lipoprotein, high-density lipoprotein, troponin-I, superoxide dismutase, catalase activity, malondialdehyde levels, and liver enzymes (SGPT and SGOT). Adrenaline administration increased total cholesterol, triglycerides, and low-density lipoprotein levels while reducing high-density lipoprotein levels. Treatment with PGLE significantly ameliorated these lipid abnormalities and improved the ratio of left ventricular weight to body weight, suggesting a decrease in LVH. Histological examinations revealed a reduction in cardiac myocyte size in PGLE-treated rats. Furthermore, PGLE administration markedly lowered troponin-I levels, boosted superoxide dismutase and catalase activities, and reduced malondialdehyde concentrations. PGLE also normalized liver enzyme levels, indicating reduced hepatic toxicity. The findings indicate that PGLE exerts potent lipid-lowering and antioxidant properties, mitigating cardiac remodeling in adrenaline-induced hypertrophic rats. Importantly, PGLE significantly decreased troponin-I levels, underscoring its potential as a therapeutic option for the prevention of LVH and associated cardiovascular conditions.
- Open Access
- Article
Attenuation of Left Ventricular Hypertrophy by Psidium guajava Leaf Extract Via Inhibition of Oxidative Stress and Cardiac Troponin I Levels in Adrenaline-Induced Hypertrophic Rats
- Rozina Khatun 1,
- Joy Sarker 1,
- Farjana Sharmin 1,2,
- Md Sabbir Hossain 1,3,
- A. B. M. Ashraful 1,4,
- A. H. M. Khurshid Alam 1,5,
- Mamunur Rashid 1,*
Author Information
Received: 31 Mar 2026 | Revised: 01 May 2026 | Accepted: 18 May 2026 | Published: 27 May 2026
Abstract
Keywords
left ventricular hypertrophy | cardiovascular disorders | ethanolic extract | adrenaline | lipid metabolism | antioxidant defense
References
- 1.
Soares, L.; Leal, T.; Faria, A.L.; et al. Cardiovascular Disease: A Review. Biomed. J. Sci. Tech. Res. 2023, 51, 42696–42703.
- 2.
Khan, S.U.; Saeed, S.; Sheikh, A.N.; et al. Crafting a Blueprint for MicroRNA in Cardiovascular Diseases (CVDs). Curr. Probl. Cardiol. 2023, 48, 102010.
- 3.
Abbasi, S.; Khan, A.; Choudhry, M.W. New Insights into the Treatment of Hyperlipidemia: Pharmacological Updates and Emerging Treatments. Cureus 2024, 16, e62789.
- 4.
Blesso, C.N.; Fernandez, M.L. Dietary Cholesterol, Serum Lipids, and Heart Disease: Are Eggs Working for or against You? Nutrients 2018, 10, 426.
- 5.
Shenasa, M.; Shenasa, H. Hypertension, Left Ventricular Hypertrophy, and Sudden Cardiac Death. Int. J. Cardiol. 2017, 237, 60–63.
- 6.
Kim, T.-H.; Yang, P.-S.; Yu, H.T.; et al. Effect of Hypertension Duration and Blood Pressure Level on Ischaemic Stroke Risk in Atrial Fibrillation: Nationwide Data Covering the Entire Korean Population. Eur. Heart J. 2019, 40, 809–819.
- 7.
Oh, G.C.; Cho, H.-J. Blood Pressure and Heart Failure. Clin. Hypertens. 2020, 26, 1.
- 8.
Shad, M.; Shah, F.S.; Zulqarnain, M.; et al. Analyzing and Identifying the Molecular Targets and Regulators Controlling Cardiac Hypertrophy Progression. NUST J. Nat. Sci. 2020, 5. https://doi.org/10.53992/njns.v5i2.47.
- 9.
Yan, Q.; Liu, S.; Sun, Y.; et al. Targeting Oxidative Stress as a Preventive and Therapeutic Approach for Cardiovascular Disease. J. Transl. Med. 2023, 21, 519.
- 10.
Donia, T.; Khamis, A. Management of Oxidative Stress and Inflammation in Cardiovascular Diseases: Mechanisms and Challenges. Environ. Sci. Pollut. Res. 2021, 28, 34121–34153.
- 11.
Abdul‑Rahman, T.; Bukhari, S.M.A.; Herrera, E.C.; et al. Lipid Lowering Therapy: An Era beyond Statins. Curr. Probl. Cardiol. 2022, 47, 101342.
- 12.
Gutierrez-Montiel, D.; Guerrero-Barrera, A.L.; Chávez-Vela, N.A.; et al. Psidium guajava L.: From Byproduct and Use in Traditional Mexican Medicine to Antimicrobial Agent. Front. Nutr. 2023, 10, 1108306.
- 13.
Kumar, M.; Tomar, M.; Amarowicz, R.; et al. Guava (Psidium guajava L.) Leaves: Nutritional Composition, Phytochemical Profile, and Health‑Promoting Bioactivities. Foods 2021, 10, 752.
- 14.
Kareem, A.T.; Kadhim, E.J. Psidium guajava: A Review on Its Pharmacological and Phytochemical Constituents. Biomed. Pharmacol. J. 2024, 17, 1079–1090.
- 15.
Bumrungpert, A.; Lilitchan, S.; Tuntipopipat, S.; et al. Ferulic Acid Supplementation Improves Lipid Profiles, Oxidative Stress, and Inflammatory Status in Hyperlipidemic Subjects: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Nutrients 2018, 10, 713.
- 16.
El-Marasy, S.A.; El Awdan, S.A.; Hassan, A.; et al. Cardioprotective Effect of Thymol against Adrenaline‑Induced Myocardial Injury in Rats. Heliyon 2020, 6, e04371.
- 17.
Aladağ, N.; Asoğlu, R.; Ozdemir, M.; et al. Oxidants and Antioxidants in Myocardial Infarction (MI): Investigation of Ischemia Modified Albumin, Malondialdehyde, Superoxide Dismutase and Catalase in Individuals Diagnosed with ST Elevated Myocardial Infarction (STEMI) and Non‑STEMI (NSTEMI). J. Med. Biochem. 2021, 40, 286–293.
- 18.
Saeedi Saravi, S.S.; Saeedi Saravi, S.S.; Arefidoust, A.; et al. The Beneficial Effects of HMG‑CoA Reductase Inhibitors in the Processes of Neurodegeneration. Metab. Brain Dis. 2017, 32, 949–965.
- 19.
Sarker, J.; Reza, A.S.M.A.; Ashraful, A.B.M.; et al. In Vitro Antioxidant and p53‑Targeted Anticancer Activity of Aerva sanguinolenta (L.) Blume across Different Human Cancer Cell Lines and Ehrlich Ascites Carcinoma Model. J. Chem. Health Risks 2026, 16, 1292–1316.
- 20.
Shaikh, J.R.; Patil, M. Qualitative Tests for Preliminary Phytochemical Screening: An Overview. Int. J. Chem. Stud. 2020, 8, 603–608.
- 21.
Ali, Y.; Islam, M.; Alam, A.; et al. Inhibitory Effects of Nigella sativa Seed Extract on Adrenaline‑Induced Dyslipidemia and Left Ventricular Hypertrophy in Rats. J. Sci. Res. 2013, 5, 325–334.
- 22.
Majewski, H.; Tung, L.-H.; Rand, M. Adrenaline-Induced Hypertension in Rats. J. Cardiovasc. Pharmacol. 1981, 3, 179–186.
- 23.
Constantin, I.; Tăbăran, A.F. Dissection Techniques and Histological Sampling of the Heart in Large Animal Models for Cardiovascular Diseases. J. Vis. Exp. 2022, 184, e63809.
- 24.
Saeed, A.; Virani, S.S.; Mulukutla, S.; et al. Dyslipidemia and Cardiovascular Disease Prevention in South Asians: A Review and Discussion of Causes, Challenges and Management Strategies. Curr. Diabetes Rev. 2021, 17, 74–86.
- 25.
Khodir, S.A.; Sweed, E.; Gadallah, M.; et al. Astaxanthin Attenuates Cardiovascular Dysfunction Associated with Deoxycorticosterone Acetate-Salt-Induced Hypertension in Rats. Clin. Exp. Hypertens. 2022, 44, 382–395.
- 26.
Vijayakumar, K.; Arumugam, V.A.; Ramasamy, M.; et al. Hepatoprotective Effects of Psidium guajava on Mitochondrial Enzymes and Inflammatory Markers in Carbon Tetrachloride-Induced Hepatotoxicity. Drug Dev. Ind. Pharm. 2020, 46, 2041–2050.
- 27.
Wen, C.; Liu, C.; Li, Y.; et al. Ameliorative Potentials of the Ethanolic Extract from Lycium chinense Leaf Extract against Diabetic Cardiomyopathy. Insight into Oxido-Inflammatory and Apoptosis Modulation. Biomed. Pharmacother. 2022, 154, 113583.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Suite 4002 Level 4, 447 Collins Street, Melbourne, Victoria 3000, Australia
General Inquiries: info@sciltp.com